The estimated Net Worth of Joseph J Larosa is at least 60.1 百万$ dollars as of 11 July 2024. Mr Larosa owns over 1,866 units of Regeneron Pharmaceuticals stock worth over 43,303,189$ and over the last 13 years he sold REGN stock worth over 15,029,211$. In addition, he makes 1,748,110$ as Exec. VP、 Gen. Counsel & Sec. at Regeneron Pharmaceuticals.
Mr has made over 23 trades of the Regeneron Pharmaceuticals stock since 2015, according to the Form 4 filled with the SEC. Most recently he sold 1,866 units of REGN stock worth 2,031,981$ on 11 July 2024.
The largest trade he's ever made was exercising 34,000 units of Regeneron Pharmaceuticals stock on 3 January 2024 worth over 13,588,440$. On average, Mr trades about 5,885 units every 81 days since 2011. As of 11 July 2024 he still owns at least 37,937 units of Regeneron Pharmaceuticals stock.
You can see the complete history of Mr Larosa stock trades at the bottom of the page.
Joseph J. LaRosa is the Exec. VP, Gen. Counsel & Sec. at Regeneron Pharmaceuticals.
As the Exec. VP、 Gen. Counsel & Sec. of Regeneron Pharmaceuticals, the total compensation of Mr LaRosa at Regeneron Pharmaceuticals is 1,748,110$. There are 13 executives at Regeneron Pharmaceuticals getting paid more, with P. Roy Vagelos having the highest compensation of 22,304,300$.
Mr LaRosa is 62, he's been the Exec. VP、 Gen. Counsel & Sec. of Regeneron Pharmaceuticals since . There are 9 older and 14 younger executives at Regeneron Pharmaceuticals. The oldest executive at Regeneron Pharmaceuticals, Inc. is P. Roy Vagelos, 90, who is the Chairman of the Board, Director.
Over the last 22 years, insiders at Regeneron Pharmaceuticals have traded over 13,084,686,326$ worth of Regeneron Pharmaceuticals stock and bought 8,562,481 units worth 2,539,854,760$ . The most active insiders traders include Sanofi、Pharma Ag Novartis、Leonard S Schleifer. On average, Regeneron Pharmaceuticals executives and independent directors trade stock every 8 days with the average trade being worth of 47,694,347$. The most recent stock trade was executed by Marion Mc Court on 3 September 2024, trading 1,000 units of REGN stock currently worth 381,400$.
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988.
Regeneron Pharmaceuticals executives and other stock owners filed with the SEC include: